Infectious Disease and Pathogen Expertise

In the face of a relentless array of infectious diseases and pathogens, preclinical research and testing stands as a critical line of defense. Southern Research is dedicated to providing comprehensive preclinical infectious disease services, empowering researchers to combat these threats and develop medical countermeasures.


Comprehensive Services Spanning the Infectious Disease Spectrum

Your Partner in Preclinical Infectious Disease Research and Testing

Our team of seasoned SMEs (subject matter experts), immunologists, and cellular biologists possesses extensive experience in understanding the pathogenesis, immmunogenicity, and disease intervention strategies for a wide range of infectious diseases. We are proficient in a variety of in vitro and in vivo infectious disease assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential therapeutics.

We offer a comprehensive suite of preclinical infectious disease services—including Select Agent and BSL-3 capabilities—tailored to address the diverse challenges posed by these diseases, encompassing every stage of the research process:

Pathogen Identification, Propagation, and Characterization: We help you identify and characterize novel pathogens, providing crucial insights into their biology and potential therapeutic targets.

Antimicrobial Compound Screening and Optimization: We utilize a range of in vitro screening assays to identify promising antimicrobial candidates and optimize their potency and spectrum of activity.

Efficacy and Safety Testing in Animal Models: We conduct rigorous efficacy and safety testing in animal models to assess therapeutic potential.

Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.

Additionally, we offer assay development, animal model development, clinical trial support, and a repository of potential pandemic pathogens.


Virology is the scientific study of viruses, a group of small, infectious agents that replicate only within living cells. Viruses can infect all types of organisms, from animals and plants to bacteria and archaea. They are responsible for a wide range of diseases, including the common cold, influenza, AIDS, and COVID-19,

Learn more about our preclinical services for virology research and testing here.


Bacteriology is a branch of microbiology that studies bacteria, a group of single-celled organisms that are ubiquitous on Earth. Bacteria are prokaryotes, which means they lack a nucleus and other membrane-bound organelles.

Learn more about our preclinical services for bacteriology research and testing here.

Emerging Pathogens

Emerging pathogens are infectious agents that have recently been discovered or have shown an increase in prevalence in human populations. These pathogens can cause new diseases or exacerbate existing ones, posing a significant threat to global health.

Learn more about our preclinical services for emerging pathogens research and testing here.

Prion Disease

Prion diseases are a class of rare, progressive, neurodegenerative disorders that affect both humans and animals. They are caused by the misfolding of a normal protein called a prion, which leads to the formation of abnormal protein aggregates in the brain and other tissues. These aggregates can damage and kill neurons, leading to a progressive decline in cognitive function and other neurological impairments.

Learn more about our preclinical services for prion disease research and testing here.


The Power of Collaboration

By partnering with Southern Research, you gain access to a wealth of expertise, resources, and infrastructure, enabling you to focus on your core competencies while we handle the complexities of preclinical infectious disease research and testing.

Our Experts

Jennifer Pickens, Ph.D.

Director of Infectious Disease Research

Fusataka Koide

Senior Director of Business Development

Rebecca Boohaker, Ph.D.

Director of Oncology

Shielding the World from Infectious Diseases Together

Southern Research is committed to safeguarding global health by providing world-class preclinical infectious disease research and testing services. We are your trusted partner in combating infectious diseases, providing you with the expertise and support you need to develop effective treatments and protect lives.

Contact us today to discuss your preclinical infectious disease research and testing needs, and let us help you make a profound impact on the fight against infectious diseases worldwide.

Southern Research News

Southern Research opens new Station 41 biotech incubator for startups

January 23, 2024

Today, Southern Research marked the official opening of its Station 41 biotech incubator, which is one of four programs that make up the newly launched Station 41 biotech commercialization hub. The incubator provides wet lab space and office space, shared lab equipment and services to support ...
Read More

Birmingham receives federal Tech Hub designation and opportunity to apply for millions in federal funding

October 23, 2023

Birmingham’s metro area is among 31 regions across the country named today as a federal Tech Hub, competing successfully under a new program that could ultimately inject $75 million into the local economy. The designation followed a highly competitive process with nearly 200 application...
Read More

Coming soon to a doctor’s office near you: Access to cutting-edge research and care

March 17, 2023

By Josh Carpenter, Ph.D. Growing up in North Alabama, I remember watching movie trailers with excitement. They always ended with a deep voice that said, “opening soon in select theaters near you.” As it turns out, those openings were never “near me” since my local theater was not one ...
Read More